Evaluation of disproportionality safety signaling applied to healthcare databases. (Q53128866)

11 May 2018

title

Evaluation of disproportionality safety signaling applied to healthcare databases. (English)

1 reference

11 May 2018

3

Martijn J Schuemie

0 references

author name string

William DuMouchel

1

1 reference

11 May 2018

Patrick B Ryan

2

1 reference

11 May 2018

Martijn J Schuemie

3

1 reference

11 May 2018

David Madigan

4

1 reference

11 May 2018

publication date

1 October 2013

1 reference

11 May 2018

published in

Drug Safety

1 reference

11 May 2018

volume

36 Suppl 1

1 reference

11 May 2018

page(s)

S123-32

1 reference

11 May 2018

Novel statistical tools for monitoring the safety of marketed drugs

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

The role of data mining in pharmacovigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Disproportionality methods for pharmacovigilance in longitudinal observational databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

A Bayesian neural network method for adverse drug reaction signal generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Desideratum for evidence based epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Managing data quality for a drug safety surveillance system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0106-Y

Determining the area under the ROC curve for a binary diagnostic test

21 January 2018

1 reference

12 December 2020

Evaluating performance of risk identification methods through a large-scale simulation of observational data

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery

1 reference

12 December 2020

10.1007/S40264-013-0106-Y

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018